Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.30% slumped 0.16% to $168.10 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +0.15% falling 0.75% to 4,327.16 and Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +0.10% falling 0.86% to 34,687.85. This was the stock's second consecutive day of losses. Johnson & Johnson closed $5.55 short of its 52-week high ($173.65), which the company reached on January 26th.
The stock underperformed when compared to some of its competitors Friday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/composite RHHVF -0.80% rose 1.98% to $388.47, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK +0.77% rose 0.15% to $78.02, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.57% rose 0.65% to $40.35. Trading volume (5.8 M) remained 593,986 below its 50-day average volume of 6.4 M.